Mengis Capital Management Inc. Increases Holdings in The Clorox Company $CLX

Mengis Capital Management Inc. boosted its position in The Clorox Company (NYSE:CLXFree Report) by 138.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 34,383 shares of the company’s stock after buying an additional 19,940 shares during the period. Mengis Capital Management Inc.’s holdings in Clorox were worth $4,239,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Total Investment Management Inc. acquired a new stake in Clorox during the 2nd quarter valued at approximately $25,000. Center for Financial Planning Inc. purchased a new position in shares of Clorox during the third quarter worth $25,000. NewSquare Capital LLC lifted its position in Clorox by 567.6% during the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after purchasing an additional 193 shares during the period. True Wealth Design LLC boosted its holdings in Clorox by 1,020.0% in the third quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after purchasing an additional 204 shares during the last quarter. Finally, Root Financial Partners LLC acquired a new stake in Clorox during the 3rd quarter worth about $29,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Down 3.0%

Clorox stock opened at $117.48 on Thursday. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. The stock has a market capitalization of $14.20 billion, a PE ratio of 19.20, a price-to-earnings-growth ratio of 0.60 and a beta of 0.59. The business has a 50 day simple moving average of $113.85 and a 200-day simple moving average of $113.67. The Clorox Company has a 12 month low of $96.66 and a 12 month high of $153.90.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. Clorox’s revenue was down .8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.55 EPS. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd will be paid a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, April 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.2%. Clorox’s payout ratio is currently 81.05%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on CLX shares. Jefferies Financial Group decreased their price objective on Clorox from $152.00 to $151.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. The Goldman Sachs Group decreased their price target on Clorox from $110.00 to $94.00 and set a “sell” rating for the company in a report on Wednesday, January 7th. Wells Fargo & Company set a $125.00 price objective on Clorox in a research report on Tuesday, February 17th. Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Finally, Morgan Stanley boosted their target price on shares of Clorox from $125.00 to $136.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $118.73.

Read Our Latest Report on CLX

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.